Fosun Health Capital Named Among 'Top 50 Value Investment & Service Institutions in China's Healthcare Industry 2026'; Portfolio Companies Featured in 'Future Healthcare 100 China 2026'

Recently, VCBeat and VB-100 officially released the “2026 Future Healthcare Top 100” series of rankings. Fukan Capital earned a spot on the “2026 China Healthcare Industry – Top 50 Value Investment and Service Institutions” list, thanks to its deep industrial ecosystem and strong performance in value investment. Meanwhile, several of its portfolio companies were successfully included in the main “2026 Future Healthcare Top 100” list and multiple sub-lists, recognized for their outstanding innovation and growth potential.

This selection aims to identify benchmark institutions capable of providing “capital empowerment + professional services” for innovative assets. This recognition marks the high industry acknowledgment of Fosun Rehab Capital’s status as a “platform-type leader” and its deep empowerment model, serving as an authoritative endorsement of its philosophy of “post-investment empowerment and value co-creation,” and further demonstrating the achievements made in collaboration with its portfolio companies.

Fujian Capital has been hailed as the “Platform Pioneer in Building the Healthcare Industry Ecosystem.”This honor not only recognizes its investment performance but also commends Fosun Rehab Capital’s unique model of leveraging industrial capital to systematically accompany and empower enterprises in achieving leapfrog growth. We look forward to Fosun Rehab Capital continuing to lead in value investing and helping China’s healthcare innovations go global.